OKYO Pharma OKYO
NASDAQ OKYO
$1.40 +0.12 (+9.38%)
As of: Nov 10, 2026 · 2:42 PM EST

OKYO Pharma (OKYO) Total Debt (2023 - 2025)

Updated

OKYO Pharma's Total Debt was $2.22 million in the year ended Mar 31, 2023.

Analysis

OKYO Pharma (OKYO) Total Debt (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 44.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 80.90 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 32.35 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 26.23 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 62.67 Bn
10 OKYO Pharma 1.37 Bn 1.34 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 185,795.00
Sep 30, 2024 1,808.00
Sep 30, 2023 2.37 Mn
Mar 31, 2023 2.22 Mn
API Access

OKYO Pharma Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=OKYO&period=max&api_key=YOUR_API_KEY